Pacific Biosciences of California, Inc. (PACB)

NASDAQ: PACB · IEX Real-Time Price · USD

1.280

+0.080 (6.67%)

At close: Jul 2, 2024, 4:00 PM

1.270

-0.010 (-0.78%)

After-hours: Jul 2, 2024, 7:59 PM EDT

PACB Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2007
Net Income	-306.74	-314.25	-181.22	29.4	-84.13	Upgrade
Depreciation & Amortization	26.53	17.32	11.59	9.3	9.95	Upgrade
Share-Based Compensation	72.12	78.61	73.36	17.53	16.4	Upgrade
Other Operating Activities	-51.09	-44.89	-14.9	-36.74	-20.53	Upgrade
Operating Cash Flow	-259.17	-263.21	-111.18	19.5	-78.31	Upgrade
Capital Expenditures	-8.84	-16.75	-5.93	-1.04	-2.84	Upgrade
Acquisitions	-0.1	0	-319.79	0	0	Upgrade
Change in Investments	13.55	133.01	-352.81	-218.28	64.88	Upgrade
Other Investing Activities	-	-0.18	-	-	-	Upgrade
Investing Cash Flow	4.6	116.08	-678.53	-219.32	62.05	Upgrade
Share Issuance / Repurchase	204.52	11.23	326.65	233.84	8.55	Upgrade
Debt Issued / Paid	-9.22	-1.61	895.18	-16	0	Upgrade
Other Financing Activities	-86.41	-	-52.25	34	18	Upgrade
Financing Cash Flow	108.89	9.62	1,170	251.84	26.55	Upgrade
Net Cash Flow	-145.68	-137.51	379.87	52.02	10.28	Upgrade
Free Cash Flow	-268.02	-279.96	-117.11	18.46	-81.15	Upgrade
Free Cash Flow Margin	-133.66%	-218.20%	-89.73%	23.40%	-89.28%	Upgrade
Free Cash Flow Per Share	-1.06	-1.25	-0.57	0.11	-0.53	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).